TRACON Pharmaceuticals (TCON) Earnings Date, Estimates & Call Transcripts $0.13 +0.03 (+29.15%) (As of 10/4/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Earnings SummaryLatest Earnings DateAug. 13EstimatedActual EPS (Aug. 13) -$0.94 Missed By -$0.94 Get TRACON Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for TCON and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTCON Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TCON Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaNext opportunity for crypto millionsOctober isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…Go here to discover the coin that could define this historic bull run with gains kicking off this mo TRACON Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.06)($0.06)($0.06)Q2 20241($1.05)($1.05)($1.05)Q3 20241($0.60)($0.60)($0.60)Q4 20241($0.29)($0.29)($0.29)FY 20244($2.00)($2.00)($2.00)TCON Earnings Date and InformationTRACON Pharmaceuticals last issued its quarterly earnings results on August 13th, 2024. The biopharmaceutical company reported ($0.94) EPS for the quarter. The firm had revenue of $0.06 million for the quarter. TRACON Pharmaceuticals has generated $0.67 earnings per share over the last year ($0.67 diluted earnings per share) and currently has a price-to-earnings ratio of 0.2. Read More TRACON Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/13/2024Q2 2024-($0.94)($0.94)($0.94)-$0.06 million5/14/2024Q1 2024($1.20)($1.33)($0.13)($1.33)-$0.10 million 3/5/2024Q4 2023($0.60)$0.20+$0.80$0.01$3.00 million$3.41 million11/9/2023Q3 2023-$5.80+$5.80$0.29--8/14/2023Q2 2023($7.20)($1.20)+$6.00$0.08-$9.00 million 5/10/2023Q1 2023($5.80)($7.20)($1.40)($0.36)-- Get the Latest News and Ratings for TCON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/8/2023Q4 2022($5.60)($6.20)($0.60)($0.31)--11/14/2022Q3 2022($6.00)($6.00)-($0.30)--8/10/2022Q2 2022($5.80)($6.20)($0.40)($0.31)--5/11/2022Q1 2022($8.20)($9.60)($1.40)($0.48)-- 3/15/2022Q4 2021($8.00)($8.00)-($0.40)-- 11/3/2021Q3 2021($6.40)($7.60)($1.20)($0.38)-- 8/11/2021Q2 2021($6.80)($11.60)($4.80)($0.58)-$0.35 million 5/5/2021Q1 2021($6.20)($6.60)($0.40)($0.33)-- 2/25/2021Q4 2020($6.80)($6.20)+$0.60($0.31)-- 11/10/2020Q3 2020($13.00)($7.60)+$5.40($0.38)-- 8/5/2020Q2 2020($14.80)($14.00)+$0.80($0.70)-- 5/13/2020Q1 2020($22.60)($15.60)+$7.00($0.78)-- 2/27/2020Q4 2019($31.60)($25.00)+$6.60($1.25)-- 11/5/2019Q3($4.00)($3.40)+$0.60($0.17)-- TRACON Pharmaceuticals Earnings - Frequently Asked Questions When did TRACON Pharmaceuticals announce their last quarterly earnings? TRACON Pharmaceuticals (NASDAQ:TCON) last announced its quarterly earning data on Tuesday, August 13, 2024. Learn more on TCON's earnings history. How much revenue does TRACON Pharmaceuticals generate each year? TRACON Pharmaceuticals (NASDAQ:TCON) has a recorded annual revenue of $12.05 million. How much profit does TRACON Pharmaceuticals generate each year? TRACON Pharmaceuticals (NASDAQ:TCON) has a recorded net income of -$3.59 million. TCON has generated $0.67 earnings per share over the last four quarters. What is TRACON Pharmaceuticals's price-to-earnings ratio? TRACON Pharmaceuticals (NASDAQ:TCON) has a trailing price-to-earnings ratio of 0.20. More Earnings Resources from MarketBeat Related Companies: VRPX Earnings Date NBSE Earnings Date CERO Earnings Date PRFX Earnings Date GRI Earnings Date ASLN Earnings Date PBLA Earnings Date PXMD Earnings Date HSTO Earnings Date DRMA Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season? This page (NASDAQ:TCON) was last updated on 10/6/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRACON Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
